Last updated on February 2019

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease

Brief description of study

The purpose of this study is to evaluate the safety and effectiveness of the study drug Mirikizumab in participants with active Crohn's Disease.

Clinical Study Identifier: NCT02891226

Contact Investigators or Research Sites near you

Start Over

There may be multiple sites ...

Toho University School of Medicine, Sakura Hospital
Sakura-shi, Japan

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.